NITYR
LIVE

Serial Number

87604011

Owner

Cycle Pharmaceuticals Ltd.

Attorney

Jaclyn Elizabeth Diffley

First Use Date

Aug 1, 2017

Filing Date

Sep 11, 2017

Add to watchlist:

No watchlists yet
View on USPTO

NITYR Trademark

Serial Number: 87604011 • Registration: 5716643

NITYR is a trademark filed by Cycle Pharmaceuticals Ltd. on September 11, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Cycle Pharmaceuticals Ltd. (23 trademarks)

The Broers Building,

Entity Type: 99

Trademark Details

Filing Date

September 11, 2017

Registration Date

April 2, 2019

First Use Anywhere

August 1, 2017

First Use in Commerce

August 1, 2017

Published for Opposition

September 4, 2018

Goods & Services

(Based on 44(e)) Pharmaceutical agents for the treatment of [ disorders of the metabolism and digestive system, pharmaceutical agents for the treatment of ] tyrosinemia [ and hypertyrosinemia, all ] in the form of [ liquids, solutions, suspensions, syrups, drops, capsules, ] tablets [ , caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; parts and fittings for all of the aforementioned goods.; pharmaceutical preparations for the treatment of disorders of the metabolism and digestive system, pharmaceutical preparations for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; pharmaceuticals for the treatment of disorders of the metabolism and digestive system, pharmaceuticals for the treatment of tyrosinemia and hypertyrosinemia all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Veterinary preparations for treatment of intestinal bacteria; veterinary preparations, namely, antioxidants; veterinary preparations namely, pain relief medications; veterinary preparations for treatment of chronic illnesses; veterinary preparations for treatment of viral diseases; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use; dietary supplements for humans and animals supplements for the treatment of disorders of the metabolism and digestive system, supplements for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; (Based on Use in Commerce) food for babies; medical dressings; plasters for medical purposes; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; biological preparations for the treatment of disorders of the metabolism and digestive system, biological preparations for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; chemical preparations for the treatment of disorders of the metabolism and digestive system, chemical preparations for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals, drug delivery agents for use in pharmaceuticals, drugs and medicines for the treatment of disorders of the metabolism and digestive system, drug delivery agents for use in pharmaceuticals, drugs and medicines for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; drugs for the treatment of rare diseases, in particular for the treatment of disorders of the metabolism and digestive system, drugs for the treatment of rare diseases, in particular for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; enzyme preparations for medical purposes, enzyme preparations for the treatment of disorders of the metabolism and digestive system, enzyme preparations for the treatment of tyrosinemia and hypertyrosinemia, medical enzyme preparations in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; enzyme preparations for veterinary purposes; medical preparations for the treatment of disorders of the metabolism and digestive systems, medical preparations for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; medicines for the treatment of disorders of the metabolism and digestive system, medicines for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches ]

[ (Based on 44(e)) Advertising services; marketing services; business management; business administration services; providing office functions; advertising and marketing relating to medical and pharmaceutical goods and services; advertising and marketing relating to pharmaceuticals, medicines and supplements for the treatment of disorders of the metabolism and digestive system; advertising and marketing relating to pharmaceuticals, medicines and supplements for the treatment of tyrosinemia and hypertyrosinemia; advertising and marketing relating to pharmaceuticals, medicines and supplements for the treatment of rare diseases; business information in the field of pharmaceuticals, medicines and supplements for the treatment of disorders of the metabolism and digestive system; business information in the field of pharmaceuticals, medicines and supplements for the treatment of tyrosinemia and hypertyrosinemia; business information in the field of pharmaceuticals, medicines and supplements for the treatment of rare diseases; business information in the field of pharmaceuticals, medicines and supplements; providing business information; on-line wholesale store services featuring pharmaceuticals, medicines and supplements for the treatment of rare diseases; on-line wholesale store services featuring medical and pharmaceutical goods and services; on-line wholesale store services featuring pharmaceuticals, medicines and supplements for the treatment of disorders of the metabolism and digestive system; on-line wholesale store services featuring pharmaceuticals, medicines and supplements for the treatment of tyrosinemia and hypertyrosinemia; promoting the goods and services of others via the internet in the medical and pharmaceutical industries; promoting the goods and services of others via the internet; retail pharmacy and drugstore services; retail store services featuring pharmaceuticals, medicines and supplements for the treatment of disorders of the metabolism and digestive system; retail store services featuring pharmaceuticals, medicines and supplements for the treatment of tyrosinemia and hypertyrosinemia; retail store services featuring pharmaceuticals, medicines and supplements for the treatment of rare diseases; retail store services featuring pharmaceuticals, medicines and supplements in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches ]

[ (Based on 44(e)) Medical services; veterinary services; hygienic and beauty care for human beings or animals; horticulture services; dispensing of pharmaceuticals, medicines and supplements for the treatment of disorders of the metabolism and digestive system; dispensing of pharmaceuticals, medicines and supplements for the treatment of rare diseases; dispensing of pharmaceuticals, medicines and supplements for the treatment of tyrosinemia and hypertyrosinemia; dispensing of pharmaceuticals, medicines and supplements; dispensing of pharmaceuticals, medicines and supplements in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; genetic testing in relation to disorders of the metabolism and digestive system; genetic testing in relation to rare diseases; genetic testing in relation to tyrosinemia and hypertyrosinemia; genetic testing for medical purposes; providing healthcare and medical information in relation to disorders of the metabolism and digestive system; providing healthcare and medical information in relation to rare diseases; providing healthcare and medical information in relation to tyrosinemia and hypertyrosinemia; providing medical product information and advisory services in relation to the treatment of disorders of the metabolism and digestive system; providing medical product information and advisory services in relation to the treatment of rare diseases; providing medical product information and advisory services in relation to the treatment of tyrosinemia and hypertyrosinemia; medical, pharmacological and pharmaceutical testing services for diagnostic and treatment purposes; medical, pharmacological and pharmaceutical testing services in relation to disorders of the metabolism and digestive system; medical, pharmacological and pharmaceutical testing services in relation to rare diseases; medical, pharmacological and pharmaceutical testing services in relation to tyrosinemia and hypertyrosinemia; providing pharmaceutical information and advisory services in relation to the treatment of disorders of the metabolism and digestive system; providing pharmaceutical information and advisory services in relation to the treatment of rare diseases; providing pharmaceutical information and advisory services in relation to the treatment of tyrosinemia and hypertyrosinemia; providing information in relation to medical, pharmacological and pharmaceutical products for the treatment of disorders of the metabolism and digestive system; providing information in relation to medical, pharmacological and pharmaceutical products for the treatment of rare diseases; providing information in relation to medical, pharmacological and pharmaceutical products for the treatment of tyrosinemia and hypertyrosinemia; providing news and information in the field of disorders of the metabolism and digestive system; providing news and information in the field of medicine in relation to tyrosinemia and hypertyrosinemia; providing news and information in the field of medicine; providing news and information in the field of rare diseases ]

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 16, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 16, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 16, 2025 REAP
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
May 21, 2025 NA85
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
May 21, 2025 C15P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 15, 2025 APRE
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Apr 16, 2025 ASCK
TEAS SECTION 8 & 15 RECEIVED
Jan 23, 2025 E815
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 3, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 3, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 3, 2024 REAP
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 2, 2024 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 15, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 15, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 15, 2022 REAP
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Oct 28, 2020 ASCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 20, 2019 TCCA
REGISTERED-PRINCIPAL REGISTER
Apr 2, 2019 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 27, 2019 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 26, 2019 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 26, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 26, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 25, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 15, 2019 GNRN
NON-FINAL ACTION E-MAILED
Feb 15, 2019 GNRT
SU - NON-FINAL ACTION - WRITTEN
Feb 15, 2019 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Feb 14, 2019 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 14, 2019 AITU
USE AMENDMENT FILED
Jan 23, 2019 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 23, 2019 EISU
CORRECTED NOA E-MAILED
Jan 17, 2019 NOAC
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 30, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 4, 2018 NPUB
PUBLISHED FOR OPPOSITION
Sep 4, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 15, 2018 NONP
ASSIGNED TO EXAMINER
Aug 10, 2018 DOCK
ELECTRONIC RECORD REVIEW COMPLETE
Aug 1, 2018 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jul 27, 2018 ERRR
ELECTRONIC RECORD REVIEW COMPLETE
Jul 24, 2018 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jul 13, 2018 ERRR
ELECTRONIC RECORD REVIEW COMPLETE
Jul 12, 2018 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jun 29, 2018 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 27, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 27, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 27, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 27, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 27, 2018 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 20, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 20, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 11, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 1, 2018 GNRN
NON-FINAL ACTION E-MAILED
May 1, 2018 GNRT
NON-FINAL ACTION WRITTEN
May 1, 2018 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 11, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 11, 2018 CRFA
ASSIGNED TO LIE
Apr 5, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 22, 2018 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 19, 2017 TCCA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 14, 2017 GNRN
NON-FINAL ACTION E-MAILED
Dec 14, 2017 GNRT
NON-FINAL ACTION WRITTEN
Dec 14, 2017 CNRT
ASSIGNED TO EXAMINER
Dec 14, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 15, 2017 NWOS
NEW APPLICATION ENTERED
Sep 14, 2017 NWAP